PMC:7102556 / 19318-19664 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"357","span":{"begin":159,"end":167},"obj":"Species"},{"id":"358","span":{"begin":168,"end":176},"obj":"Species"},{"id":"359","span":{"begin":272,"end":280},"obj":"Species"},{"id":"360","span":{"begin":328,"end":336},"obj":"Species"},{"id":"361","span":{"begin":337,"end":345},"obj":"Species"},{"id":"370","span":{"begin":116,"end":125},"obj":"Chemical"},{"id":"371","span":{"begin":192,"end":211},"obj":"Chemical"},{"id":"372","span":{"begin":217,"end":226},"obj":"Chemical"}],"attributes":[{"id":"A357","pred":"tao:has_database_id","subj":"357","obj":"Tax:694009"},{"id":"A358","pred":"tao:has_database_id","subj":"358","obj":"Tax:9606"},{"id":"A359","pred":"tao:has_database_id","subj":"359","obj":"Tax:9606"},{"id":"A360","pred":"tao:has_database_id","subj":"360","obj":"Tax:1335626"},{"id":"A361","pred":"tao:has_database_id","subj":"361","obj":"Tax:9606"},{"id":"A370","pred":"tao:has_database_id","subj":"370","obj":"MESH:D012254"},{"id":"A371","pred":"tao:has_database_id","subj":"371","obj":"MESH:C558899"},{"id":"A372","pred":"tao:has_database_id","subj":"372","obj":"MESH:D012254"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Despite the antiviral activity observed with in vitro studies, the clinical effect was not consistent [75], in that ribavirin does not prolong the survival of SARS-CoV patients [74,76], while lopinavir/ritonavir plus ribavirin seemed to improve clinical outcomes for SARS patients [77], but the improvement was not confirmed in MERS-CoV patients."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T72","span":{"begin":159,"end":167},"obj":"Disease"},{"id":"T73","span":{"begin":267,"end":271},"obj":"Disease"}],"attributes":[{"id":"A72","pred":"mondo_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Despite the antiviral activity observed with in vitro studies, the clinical effect was not consistent [75], in that ribavirin does not prolong the survival of SARS-CoV patients [74,76], while lopinavir/ritonavir plus ribavirin seemed to improve clinical outcomes for SARS patients [77], but the improvement was not confirmed in MERS-CoV patients."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T208","span":{"begin":22,"end":30},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Despite the antiviral activity observed with in vitro studies, the clinical effect was not consistent [75], in that ribavirin does not prolong the survival of SARS-CoV patients [74,76], while lopinavir/ritonavir plus ribavirin seemed to improve clinical outcomes for SARS patients [77], but the improvement was not confirmed in MERS-CoV patients."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T131","span":{"begin":12,"end":21},"obj":"Chemical"},{"id":"T132","span":{"begin":116,"end":125},"obj":"Chemical"},{"id":"T133","span":{"begin":192,"end":211},"obj":"Chemical"},{"id":"T134","span":{"begin":192,"end":201},"obj":"Chemical"},{"id":"T135","span":{"begin":202,"end":211},"obj":"Chemical"},{"id":"T136","span":{"begin":217,"end":226},"obj":"Chemical"}],"attributes":[{"id":"A131","pred":"chebi_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A132","pred":"chebi_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/CHEBI_63580"},{"id":"A133","pred":"chebi_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A134","pred":"chebi_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A135","pred":"chebi_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A136","pred":"chebi_id","subj":"T136","obj":"http://purl.obolibrary.org/obo/CHEBI_63580"}],"text":"Despite the antiviral activity observed with in vitro studies, the clinical effect was not consistent [75], in that ribavirin does not prolong the survival of SARS-CoV patients [74,76], while lopinavir/ritonavir plus ribavirin seemed to improve clinical outcomes for SARS patients [77], but the improvement was not confirmed in MERS-CoV patients."}

{"project":"LitCovid-sentences","denotations":[{"id":"T123","span":{"begin":0,"end":346},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Despite the antiviral activity observed with in vitro studies, the clinical effect was not consistent [75], in that ribavirin does not prolong the survival of SARS-CoV patients [74,76], while lopinavir/ritonavir plus ribavirin seemed to improve clinical outcomes for SARS patients [77], but the improvement was not confirmed in MERS-CoV patients."}

{"project":"2_test","denotations":[{"id":"32017984-25278221-69697785","span":{"begin":178,"end":180},"obj":"25278221"},{"id":"32017984-26228937-69697786","span":{"begin":181,"end":183},"obj":"26228937"},{"id":"32017984-14985565-69697787","span":{"begin":282,"end":284},"obj":"14985565"}],"text":"Despite the antiviral activity observed with in vitro studies, the clinical effect was not consistent [75], in that ribavirin does not prolong the survival of SARS-CoV patients [74,76], while lopinavir/ritonavir plus ribavirin seemed to improve clinical outcomes for SARS patients [77], but the improvement was not confirmed in MERS-CoV patients."}